Nature's Way, a pioneer in the vitamins and supplements industry for over 50 years, announces today the reformulation of ...

Catalyst (CPRX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate ...

Shares of Catalyst Pharmaceuticals rose as the company reached a settlement agreement with Teva Pharmaceuticals related to Teva's plans for a generic version of Firdapse 10 mg tablets. Catalyst stock ...

Catalyst Pharmaceuticals and its licensor SERB entered into a settlement agreement with Teva Pharmaceuticals resolving patent litigation brought by Catalyst and SERB in response to Teva's plans for a ...

Shares of Catalyst Pharmaceuticals (CPRX) have resumed trading and are higher after the company announced that the company and its licensor ...

Catalyst Pharmaceuticals (CPRX) announced that the company and its licensor SERB S.A. have entered into a Settlement Agreement with Teva ...

Recent NHS statistics show that the number of people in England being admitted to hospital for illnesses relating to a lack of vitamins is rising dramatically. Experts advise on warning signs to look ...

10 mg/week) Ergotamine/caffeine – Cafergot® 1 mg/100 mg tabs, 2 mg/100 mg rectal suppositories Two tablets p.o., then 1 q30min × 4 PRN (max six tablets/attack), one rectal suppository ...

Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing ...

Catalyst Pharmaceuticals (NASDAQ:CPRX) stock jumped 15% Wednesday on news the company had reached an agreement with Teva ...

It was a busy week in the biotech sector, with many regulatory and pipeline updates. Neumora Therapeutics NMRA plummeted on the announcement of a study failure, while Hoth Therape ...

Diving into men's health trends, a startling statistic caught my attention: 52% of men encounter erectile dysfunction, ...